About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Receives Further Arbitration Process Update
October 23, 2018
Click here to read more
Post navigation
Previous Post
Phosphagenics Licencing Agreement Update
Next Post
Receipt of R&D Tax Incentive
Related Posts
Avecho licenses TPM® for development of enhanced cancer drugs
May 22, 2023
May 22, 2023
Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan
November 10, 2016
2018 AGM Results
May 28, 2018